SONIDEGIB PHOSPHATE
| Brand name | ODOMZO |
|---|---|
| Active ingredient | SONIDEGIB PHOSPHATE |
| Strength | EQ 200MG BASE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2015 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10266523 | March 2036 | substance, product |
| 8063043 | September 2029 | substance, product |
| 8178563 | July 2029 | substance |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.